Mitocytosis Mediated by an Enzyme‐Activable Mitochondrion‐Disturbing Polymer‐Drug Conjugate Enhances Active Penetration in Glioblastoma Therapy
Advanced Materials · 2024-05 · 36 (18)
DOI: 10.1002/adma.202311500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 08.02.2024. Verfasst von Yufan Xiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Department of Radiology, Neurosurgery Research Laboratory, Huaxi MR Research Center (HMRRC), Frontiers Science Center for…. Hauptthemen laut MEDLINE: Mitochondria, Glioblastoma, Polymers. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, West China Hospital, Sichuan University.
Abstract (Originalsprache)
The application of nanomedicines for glioblastoma (GBM) therapy is hampered by the blood–brain barrier (BBB) and the dense glioblastoma tissue. To achieve efficient BBB crossing and deep GBM penetration, this work demonstrates a strategy of active transcellular transport of a mitochondrion‐disturbing nanomedicine, pGBEMA 22 ‐ b ‐pSSPPT 9 (GBEPPT), in the GBM tissue through mitocytosis. GBEPPT is computer‐aided designed and prepared by self‐assembling a conjugate of an amphiphilic block polymer and a drug podophyllotoxin (PPT). When GBEPPT is delivered to the tumor site, overexpressed γ‐glutamyl transpeptidase (GGT) on the brain–blood endothelial cell, or the GBM cell triggered enzymatic hydrolysis of γ‐glutamylamide on GBEPPT to reverse its negative charge to positive. Positively charged GBEPPT rapidly enter into the cell and target the mitochondria. These GBEPPT disturb the homeostasis of mitochondria, inducing mitocytosis‐mediated extracellular transport of GBEPPT to the neighboring cells via mitosomes. This intracellular‐to‐intercellular delivery cycle allows GBEPPT to penetrate deeply into the GBM parenchyma, and exert sustainable action of PPT released from GBEPPT on the tumor cells along its penetration path at the tumor site, thus improving the anti‐GBM effect. The process of mitocytosis mediated by the mitochondrion‐disturbing nanomedicine may offer great potential in enhancing drug penetration through malignant tissues, especially poorly permeable solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Department of Radiology, Neurosurgery Research Laboratory, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy…
- Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
- Functional and Molecular Imaging Key Laboratory of Sichuan Province, and Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, 610041, China.
- Department of Radiology, West China Xiamen Hospital of Sichuan University, Xiamen, 361021, China.
ORCID-Profile: Kui Luo
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- West China Hospital, Sichuan University
Zitieren
APA
Xiang, Y., Wang, B., Yang, W., Zheng, X., Chen, R., Gong, Q., Gu, Z., Liu, Y., & Luo, K. (2024). Mitocytosis Mediated by an Enzyme‐Activable Mitochondrion‐Disturbing Polymer‐Drug Conjugate Enhances Active Penetration in Glioblastoma Therapy. Advanced Materials, 36(18). https://doi.org/10.1002/adma.202311500
Vancouver
Xiang Y, Wang B, Yang W, Zheng X, Chen R, Gong Q, et al. Mitocytosis Mediated by an Enzyme‐Activable Mitochondrion‐Disturbing Polymer‐Drug Conjugate Enhances Active Penetration in Glioblastoma Therapy. Advanced Materials. 2024;36(18). doi:10.1002/adma.202311500
BibTeX
@article{Xiang2024,
author = {Xiang, Yufan and Wang, Bing and Yang, Wanchun and Zheng, Xiuli and Chen, Rongjun and Gong, Qiyong and Gu, Zhongwei and Liu, Yanhui and Luo, Kui},
title = {Mitocytosis Mediated by an Enzyme‐Activable Mitochondrion‐Disturbing Polymer‐Drug Conjugate Enhances Active Penetration in Glioblastoma Therapy},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {18},
doi = {10.1002/adma.202311500}
}
EUVIMED